At close: December 13 at 4:00:01 PM EST
After hours: 7:43:44 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
--
--
1,000.00
--
Operating Expense
99,980.00
102,558.00
62,029.00
50,860.00
37,025.00
Operating Income
-99,980.00
-102,558.00
-62,029.00
-49,860.00
-37,025.00
Net Non Operating Interest Income Expense
12,479.00
12,901.00
2,110.00
170.00
55.00
Other Income Expense
-303.00
-314.00
-68.00
40.00
-2,788.00
Pretax Income
-87,804.00
-89,971.00
-59,987.00
-49,650.00
-39,758.00
Tax Provision
269.00
239.00
358.00
508.00
813.00
Net Income Common Stockholders
-88,073.00
-90,210.00
-60,345.00
-50,158.00
-29,352.00
Diluted NI Available to Com Stockholders
-88,073.00
-90,210.00
-60,345.00
-50,158.00
-29,352.00
Basic EPS
-1.18
-1.27
-1.67
-2.21
-1.29
Diluted EPS
-1.18
-1.27
-1.67
-2.21
-1.29
Basic Average Shares
74,762.14
71,259.24
36,033.05
22,705.95
22,721.72
Diluted Average Shares
74,762.14
71,259.24
36,033.05
22,705.95
22,721.72
Total Operating Income as Reported
-99,980.00
-102,558.00
-62,029.00
-49,860.00
-37,025.00
Total Expenses
99,980.00
102,558.00
62,029.00
50,860.00
37,025.00
Net Income from Continuing & Discontinued Operation
-88,073.00
-90,210.00
-60,345.00
-50,158.00
-40,053.00
Normalized Income
-88,073.00
-90,210.00
-60,345.00
-50,158.00
-40,053.00
Interest Income
12,479.00
12,901.00
2,110.00
170.00
55.00
Net Interest Income
12,479.00
12,901.00
2,110.00
170.00
55.00
EBIT
-99,980.00
-102,558.00
-62,029.00
-49,860.00
-37,025.00
EBITDA
-99,078.00
-101,677.00
-60,997.00
-49,348.00
-36,631.00
Reconciled Depreciation
902.00
881.00
1,032.00
512.00
394.00
Net Income from Continuing Operation Net Minority Interest
-88,073.00
-90,210.00
-60,345.00
-50,158.00
-40,053.00
Normalized EBITDA
-99,078.00
-101,677.00
-60,997.00
-49,348.00
-36,631.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
12/31/2020 - 2/5/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ALT Altimmune, Inc.
9.03
+5.12%
GPCR Structure Therapeutics Inc.
31.25
-1.45%
CRVS Corvus Pharmaceuticals, Inc.
7.38
-8.66%
VKTX Viking Therapeutics, Inc.
47.03
-1.75%
KROS Keros Therapeutics, Inc.
18.83
+2.17%
RVPHW Reviva Pharmaceuticals Holdings, Inc.
0.3100
-11.40%
ANAB AnaptysBio, Inc.
15.59
+3.79%
APVO Aptevo Therapeutics Inc.
4.0900
-27.35%
MDGL Madrigal Pharmaceuticals, Inc.
304.50
+0.67%
RVPH Reviva Pharmaceuticals Holdings, Inc.
2.6100
-5.78%